FMR CORP 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-10 10:13 am Sale |
2022-05-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 222,990 0.492% |
-3,654,062 (-94.25%) |
Filing |
| 2022-02-09 09:19 am Sale |
2022-02-08 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 3,877,052 8.178% |
-873,437 (-18.39%) |
Filing |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 4,750,489 10.615% |
634,841 (+15.43%) |
Filing |
| 2021-02-08 10:21 am Purchase |
2021-02-05 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 4,115,648 9.196% |
4,115,648 (New Position) |
Filing |